TRANSCEND Sorena Nadaf, M.S., M.MI Director Translational Informatics, CIO Translational Informatics caBIG CTMS and Imaging Workspace F2F March 19 th,

Slides:



Advertisements
Similar presentations
27 June 2005caBIG an initiative of the National Cancer Institute, NIH, DHHS caBIG the cancer Biomedical Informatics Grid Arumani Manisundaram caBIG - Project.
Advertisements

Common Terminology Criteria for Adverse Events (CTCAE) v.4: Updating a Cancer Research Standard Ann Setser 1, Ranjana Srivastava 2, Lawrence Wright 1,
CTSA KFC Meeting October 28, 2009 UIC Center for Clinical and Translational Science (CCTS): Biomedical Informatics Core.
ACRIN 6698 Protocol: Diffusion-weighted MR Imaging Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: A sub-study of the ISPY-2.
Enterprise Use Cases. Levels LevelDescriptionExamples 0 0aVerbal CommunicationNon-permanent, e.g. verbal communication 1Non-electronic dataMail, phone.
CHOICE Pathology Informatics 2010 Boston, Massachusetts DataReady ® : A Deployable Data Management and Integration System for Large-scale Cancer Repositories.
All Rights Reserved, Duke Medicine 2007 Duke Cancer Institute caBIG Implementation Strategy Presented to caBIG Architecture WS May 06, 2011 Pankaj Agarwal.
Overview of Biomedical Informatics Rakesh Nagarajan.
Cancer Nanotechnology: New Opportunities for Targeted Therapies FDA Public Meeting October 10, 2006 Piotr Grodzinski, Ph.D. Director, Nanotechnology for.
Neil Cowles, Chief Executive Officer OPEN SOURCE SOLUTIONS FOR HEALTHCARE INFORMATION Tolven Update February 2011.
The cancer Biomedical Informatics Grid™ (caBIG™): In Vivo Imaging Workspace Projects Fred Prior, Ph.D. Mallinckrodt Institute of Radiology Washington University.
The NIH Roadmap for Medical Research
Informatics in Breast Cancer Research I-SPY 2 TRIAL & TRANSCEND Sarah Davis, MS University of California, San Francisco December 6, 2011.
ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:
Vanderbilt University NascaBIG ® TBPT Face-to-Face Meeting December 6-7, 2011 Nashville, TN caBIG ® TBPT Face-to-Face Meeting December 6-7, 2011 Vanderbilt.
SCIENCE-DRIVEN INFORMATICS FOR PCORI PPRN Kristen Anton UNC Chapel Hill/ White River Computing Dan Crichton White River Computing February 3, 2014.
ArtClinica Address: 1175 Marlkress Rd, #2632, Cherry Hill, NJ 08034, USAPhone: Fax: ARTClinica.
Shared Health Research Information Network Andrew McMurry, MS SHRINE Architect Harvard Medical School Center for BioMedical Informatics Children’s Hospital.
Grants. The mission of the Quantitative Imaging Network (QIN) is to improve the role of quantitative imaging for clinical decision making in oncology.
The Cancer Biomedical Informatics Grid: An Information Infrastructure for Healthcare and Life Sciences Amy Walker CEO and Healthcare IT Strategist Center.
1 Communication & Care Plan for Breast Cancer Treatment Creating a Tool for Patient-Centered Care Kathy Hajopoulos, MPH UCSF Carol Franc Buck Breast Care.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Imaging Workspace An Overview and Roadmap Eliot L. Siegel, MD Imaging Workspace Lead SME January 23, 2008.
Department of Biomedical Informatics Service Oriented Bioscience Cluster at OSC Umit V. Catalyurek Associate Professor Dept. of Biomedical Informatics.
 BRIDG R3.0.2 was released in August 2010  The BRIDG Model passed the initial ISO Joint Initiative Council ballot as a Draft International Standard (DIS)
Cancer Clinical Trial Suite (CCTS): An Introduction for Users A Tool Demonstration from caBIG™ Bill Dyer (NCI/Pyramed Research) June 2008.
Using the Open Metadata Registry (openMDR) to create Data Sharing Interfaces October 14 th, 2010 David Ervin & Rakesh Dhaval, Center for IT Innovations.
Anticipated FY2016 Appropriations Agency$ Million NIH200 Cancer70 Cohort130 FDA10 Office of the Natl Coord. for Health IT (ONC) 5 TOTAL215 Mission: To.
Sage Bionetworks A non-profit organization with a vision to enable networked team approaches to building better models of disease BIOMEDICINE INFORMATION.
The National Biomedical Imaging Archive (NBIA) In Action: An Introduction for Users A Tool Demonstration from caBIG® Presented by: Eliot Siegel, MD Maryland.
A Model-Driven Approach to Interoperability and Integration in Systems of Systems Gareth Tyson Adel Taweel Steffen Zschaler Tjeerd Van Staa Brendan Delaney.
CaMATCH Pilot Project1 Pilot Project : caMATCH Matching Patients to Clinical Trials A Contribution to Strategic Research and Standards Development for.
H Using the Open Metadata Registry (OpenMDR) to generate semantically annotated grid services Rakesh Dhaval, MS, Calixto Melean,
CRIX: toward a secure, standards-based, clinical research information exchange.
Treatment Summary University of California San Francisco Center of Excellence for Breast Cancer Care PI: Laura J Esserman MD MBA; Edward Mahoney; Elly.
CaBIG ® VCDE Workspace Tactics thru June 14, 2010: How working groups fit together, and other activities Brian Davis April 1, 2010 VCDE WS Teleconference.
Informatics in Breast Cancer Research I-SPY 2 TRIAL & TRANSCEND.
1 LS DAM Overview and the Specimen Core February 16, 2012 Core Team: Ian Fore, D.Phil., NCI CBIIT, Robert Freimuth, Ph.D., Mayo Clinic, Elaine Freund,
Cancer MetaData Standards Peter A. Covitz, Ph.D. HL7 RCRIM October 1, 2002.
Sage Bionetworks A non-profit organization with a vision to enable networked team approaches to building better models of disease BIOMEDICINE INFORMATION.
THE MURDOCK Study: A Rich Data Resource for Biomarker Discovery and Validation Brian D. Bennett 1, Jessica D. Tenenbaum 1, Victoria Christian 1, Melissa.
Introduction to caIntegrator caBIG ® Molecular Analysis Tools Knowledge Center April 3, 2011.
Interchange vs Interoperability Main Entry: in·ter·op·er·a·bil·i·ty : ability of a system... to use the parts or equipment of another system Source: Merriam-Webster.
DRAFT of Proposed TRANSCEND Integration Architecture March 2011.
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
The National Cancer Imaging Archive (NCIA) In Action: An Introduction for Users A Tool Demonstration from caBIG™ Carl Jaffe, MD NCI-Cancer Imaging Program.
Subject Registrations Adverse Events Subject Registrations Biospecimens Lab Results IN: 1. Lab Results OUT: 1. Subject Registrations 2. Clinical Notes.
Structured Protocol Representation for the Cancer Biomedical Informatics Grid: caSPR and caPRI.
May 2007 CTMS / Imaging Interoperability Scenarios March 2009.
Welcome to the caBIG Community! The cancer Biomedical Informatics Grid (caBIG ® ) offers more than 120 open source tools, technologies and infrastructure.
Uses of the NIH Collaboratory Distributed Research Network Jeffrey Brown, PhD for the DRN Team Harvard Pilgrim Health Care Institute and Harvard Medical.
Imaging Workspace An Overview and Roadmap Eliot L. Siegel, MD Imaging Workspace Lead SME January 23, 2008.
1 LS DAM Overview August 7, 2012 Current Core Team: Ian Fore, D.Phil., NCI CBIIT, Robert Freimuth, Ph.D., Mayo Clinic, Mervi Heiskanen, NCI-CBIIT, Joyce.
CaTissue Suite 1.2 TPBT Face to Face Michelle Lee, MBA, Ph.D. Ian Fore, D. Phil. December, 2009.
CTMS Group Call Focus - Changes Michele Ehlman Essex Management Michael Otjen Sapient Paul Davis Essex Management.
Cancer Central Clinical Participant Registry (C3PR) v2.5 CTMS WS September 22, 2009 Pankaj Agarwal 1, Ram Chilukuri 2 1 Duke Comprehensive Cancer Center.
June 2009, Ann Arbor, Michigan Tissue Banks and Pathology Tools Workspace Face to Face Ian Fore, DPhil Center for Bioinformatics, National Cancer Institute.
0 caBIG and caGrid: Interoperable Computing Infrastructure for the Nation’s [and World’s] Cancer Research Enterprise Peter A. Covitz, Ph.D. Chief Operating.
Mentors, Compatibility Reviewers, VCDE WS participants VCDE WS Telecom December 4, 2008.
ARCH/VCDE F2F BoF And the Presentation Subtitle Goes Here Ravi Madduri December 2008.
VCDE WS in EY2 Where we are, where we’re going ICR WS Teleconference Brian Davis – VCDE WS Lead March 26, 2008.
© Akaza Research, LLC : 1 :: 10 Professional open source for clinical research.
C3PR: An Introduction for Users A Tool Demonstration from caBIG™ Vijaya Chadaram Duke Cancer Center April 29, 2008.
Semantic Web - caBIG Abstract: 21st century biomedical research is driven by massive amounts of data: automated technologies generate hundreds of.
Jim Bland Executive Director, CRIX International
Cardiovascular Diseases Faculty of Medicine Second Annual Retreat
Clinical Observation Interoperability March 18, 2008
Clinical and Translational Science Awards Program
Presentation transcript:

TRANSCEND Sorena Nadaf, M.S., M.MI Director Translational Informatics, CIO Translational Informatics caBIG CTMS and Imaging Workspace F2F March 19 th, 2009

Translational Informatics 2 TRANSCEND project TRANslational Informatics System to Coordinate Emerging Biomarkers, Novel Agents, and Clinical Data … “Informatics Integration”

Translational Informatics Key Partners and Stakeholders UCSF Sorena Nadaf – PI Laura Esserman – PI Kathy Hajopolous – Project Lead Sarah Davis – Project Mgt & I-SPY 2 Meg Young – Project Manager Nola Hilton – Imaging Laura van' Veer – I-SPY 2 UC Davis Mike Hogarth – Design Lead Davera Gabriel - Ontologist UPenn Angi DeMichele – Oncologist Georgetown Subha Madhavan – Tech Consultant MD Anderson Kyle Wathen – Randomization Service Duke Pankaj Agarwal – Architect Mentor SAIC-F Nancy Roche – COTR Manager Liming Shen - caTISSUE NCI John Speakman – CTMS PO Ian Fore – TBPT PO Christo Andonyadis – CTMS Denise Warzel – Program Mgt John Koisch – Architect, COPPA Anan Basu – caINTEGRATOR FDA Linda Doody – CRO Regulatory 3 rd Millennium Brian Davis – VCDE Consultant CCSA Dan Milgram – CRO Informatics Donya Baghari – CRO Mgt Tolven John Churin – Architect Tom Jones – CMO Neil Cowles – Strategy Pure InfoDesign Michael Moore – UI Consultant Ekagra Kalpesh Patel – Integrations 3

Translational Informatics 4 TRANSCEND’s Top 10 Develop and deploy a nationally scalable Informatics Infrastructure to meet multi center adaptive design clinical trials Utilize NCI caBIG compatible tools and architecture in the design of the Informatics Infrastructure Demonstrate the use of web-based case report forms (CRFs) to facilitate data collection and transmission to the NCI Demonstrate how electronic clinical data collection can automate CRF generation Demonstrate the integration of an electronic health record system with an caBIG based translational research infrastructure

Translational Informatics 5 TRANSCEND’s Top 10 Continued Demonstrate the use of caBIG standards in the integration of a clinical care system with other caBIG tools (caINTEGRATOR, caTISSUE) Extend the caBIG standards for clinical data elements, using coded, controlled vocabularies Connect system interfaces in constructing a translational research platform spanning genomic / proteomic, radiographic, and clinical data Evaluate the efficacy of the TRANSCEND infrastructure in collecting high quality, real-time, and complete structured phenotypic data from next generation clinical trials Be “Adaptive” in Clinical Trials – Smart Clinical Trials

Translational Informatics Being “adaptive” in trials requires technology to be “adaptive” An iterative approach to evaluating therapeutic interventions/agents Differs from traditional trials Adaptive functional requirements –Study participants can be excluded from arms based on biological characterization of their tumors –Treatment Arms (ie, agents) added/removed throughout the trial – a “running trial” –Outcome “measures” can be modified as technology advances – leverage new biomarker assays as they are validated and become available

Translational Informatics TRANSCEND Informatics Key requirements for TRANSCEND –Fast and correct information capture minimize ‘data cleaning’/scrubbing –Expedient access to study information manage a multi-site trial as a single enterprise, not “multiple sites” –Facilitated information sharing analysis of trial data by anyone who can connect…(after appropriate vetting and authentication / authorization)

Translational Informatics TRANSCEND Requirements Manage the registration lifecycle Manage eligibility determination Randomize patients Track study participants Manage bio-specimens Capture clinical data at the point of care and render CRF’s using automated methods Provide most sites with Web-based traditional CRFs Manage patient calendars and treatment planning (CCP) Manage the Severe Adverse Event (SAE) lifecycle Provide for storage and retrieval of raw and interpreted data in a repository (caINTEGRATOR)

Translational Informatics 9 TRANSCEND Primary Components Automated transformation of data captured at the point of care to CRF-based reportable data Web Based CRF Clinical Data Capture within an electronic health record system Integration from electronic health record to Biospecimen Management and Tracking (caTISSUE) Integration to Adaptive Design Randomization Engine through a web-service AE / SAE Reporting and Management Storage of Array Data Storage and analysis of trial data

Translational Informatics 10 TRANSCEND caBIG Tools caTISSUE Suite – Biospecimen Management and Tracking caINTEGRATOR – Data Analysis Portal caXchange – Facilitate Electronic Messaging caARRAY – Micro Array data repository ? caAERS ? – Adverse and Serious Adverse Event Reporting caDSR – Where we will derive core set CDE’s required in the CRF’s BRIDGE* – –HL7 Messaging System Interfaces –Using caXchange and HL7 friendly enterprise bus –When possible, align TRANSCEND information model with BRIDGE

Translational Informatics 11 TRANSCEND Vision & Primary Case Study Encompasses: –Clinical Trial Patient Management –Patient Trial Registration –Biospecimen Management –Storage of raw test result data –Provisioning of a data analysis portal for Investigators to analyze trial results on an ongoing basis Developed in Unison with I-SPY 2 –Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And molecular analysis –Innovative multi-center adaptive breast cancer clinical trial –Studying use of Novel Agents, Biomarkers, and MRI in neo- adjuvant therapy for women who have locally advanced Breast Cancer –IDEAL test case for TRANSCEND

Translational Informatics Background Summary for I-SPY1  2 I-SPY 1 evaluated biomarkers and imaging for predicting response to std neoadjuvant chemotherapy I-SPY 2 will evaluate phase II drugs in combination with standard chemotherapy in a neoadjuvant setting I-SPY 2 will use biomarkers to stratify patients based on their predicted likelihood of response to treatment I-SPY 2 will use imaging to measure response Surgery Anthracycline Taxane Clinical Study I-SPY 1: (2002–Present) I-SPY 2: (2009–2012)

Translational Informatics 13 caBIG’s CCTS

Translational Informatics 14 TRANSCEND Trial Infrastructure Mike Hogarth

Translational Informatics 15 TRANSCEND Deployment View Mike Hogarth

Translational Informatics 16 TRANSCEND Deployment View Mike Hogarth

Translational Informatics 17 TRANSCEND

Translational Informatics 18 Translational Informatics Program Enable the HDFCCC to optimize the translation of basic discoveries into practical clinical applications Deliver suite of services to support translational, biomedical, clinical research and clinical care improvement

Translational Informatics Component Acknowledgments System Design –Michael Hogarth –Laura Esserman –Sorena Nadaf –Subha Madhava Architecture –Mike Hogarth –John Koich Clinical Team –Angie DeMichele –Mary Lou Ernest –Michael Moore –Laura Esserman Project Management –Kathy Hajopoulos –Meg Young Trial Support Team –Sarah Davis –Meredith Buxton Technical Teams –Tolven Team John Churrin Tom Jones Neil Cowles –NCI caBIG teams caTISSUE, ca INTEGRATOR –Subha Madhava

Translational Informatics Plug: 1 st Annual Cancer Center Translational Informatics Conference University of California San Francisco Helen Diller Family Comprehensive Cancer Center October 2010

Questions and Answers